SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 1996 W. R. GRACE & CO. (Exact name of registrant as specified in its charter) New York 1-3720 13-3461988 (State or other (Commission File (IRS Employer jurisdiction of Number) Identification No.) incorporation) One Town Center Road, Boca Raton, Florida 33486-1010 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 407/362-2000 Item 5. Other Events. On April 8, 1996, W. R. Grace & Co. ("Company") announced that it had entered into a definitive agreement to sell the transgenic plant business of its Agracetus subsidiary to the Monsanto Company for $150 million. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. The press release issued by the Company on April 8, 1996 regarding the matter described in Item 5 above is being filed as an exhibit to this Report. - 2 - SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed by the undersigned thereunto duly authorized. W. R. GRACE & CO. ------------------ (Registrant) By s/Robert B. Lamm -------------------- Robert B. Lamm Vice President and Secretary Dated: April 15, 1996 - 3 - W. R. GRACE & CO. Current Report on Form 8-K Exhibit Index Exhibit No. Description - ----------- ----------- 99.1 Press Release issued by the Company on April 8, 1996 - 4 -